Literature DB >> 21719415

Interleukin-19: a new target to aim for?

Ceri A Fielding.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719415     DOI: 10.1093/rheumatology/ker174

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

1.  The Difference in Interleukin-19 Serum on Degrees of Acne Vulgaris Severity.

Authors:  Moerbono Mochtar; Alamanda Murasmita; M Eko Irawanto; Indah Julianto; Harijono Kariosentono; Fajar Waskito
Journal:  Int J Inflam       Date:  2018-04-01

2.  PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma.

Authors:  S Lagger; L Kenner; I Garces de Los Fayos Alonso; L Zujo; I Wiest; P Kodajova; G Timelthaler; S Edtmayer; M Zrimšek; S Kollmann; C Giordano; M Kothmayer; H A Neubauer; S Dey; M Schlederer; B S Schmalzbauer; T Limberger; C Probst; O Pusch; S Högler; S Tangermann; O Merkel; A I Schiefer; C Kornauth; N Prutsch; M Zimmerman; B Abraham; J Anagnostopoulos; L Quintanilla-Martinez; S Mathas; P Wolf; D Stoiber; P B Staber; G Egger; W Klapper; W Woessmann; T A Look; P Gunning; S D Turner; R Moriggl
Journal:  Mol Cancer       Date:  2022-08-31       Impact factor: 41.444

3.  Association of BCL2 polymorphisms and the IL19 single nucleotide polymorphism rs2243188 with systemic lupus erythematosus.

Authors:  Weijie Wang; Xinchang Wang; Kepeng Yang; Yongsheng Fan
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.